Physician profile
William Arroyo
NPI 1053608216
$55,393.92
in general payments reported to CMS, 2019-2025
16 companies · $2,909 in 2025
The $2,909 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,719 · 2020: $5,384 · 2021: $12K · 2022: $3,965 · 2023: $7,706 · 2024: $22K · 2025: $2,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $5,591 · Food and Beverage: $3,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,725.00 |
| Travel and Lodging | $5,590.91 |
| Food and Beverage | $3,997.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $22,327.01 | 2021-2024 | Healix Knotless Peek |
| Smith+Nephew, INC. | $13,459.36 | 2019-2025 | Journey, Ri Hip Navigation, Or3o Dual Mobility |
| Depuy Synthes Products, INC. | $6,637.50 | 2021-2025 | |
| Micromed INC | $3,811.32 | 2020-2021 | |
| Stryker Corporation | $3,175.37 | 2021-2025 | Pangea, Gamma, Bio4 |
| Rattan and Associates | $2,674.27 | 2021-2023 | |
| Arthrex, INC. | $919.27 | 2022-2023 | |
| Miach Orthopaedics, INC. | $822.32 | 2024-2025 | |
| Depuy Synthes Sales INC. | $656.84 | 2020-2025 | Truespan Orthocord, Healix Knotless Peek, Fms |
| Heraeus Medical, LLC. | $396.81 | 2022-2024 | Palacos |
| Merz North America, INC. | $177.30 | 2025 | |
| Linvatec Corporation | $126.01 | 2023 | Biobrace 23mm |
| Bioventus LLC | $111.58 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $58.62 | 2025 | |
| Vericel Corporation | $23.52 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $16.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.